AAFM Boards Dermatology Practice Test

The correct percentage indicating that a significant portion of COVID-19 patients experience pruritus along with vesicular and urticarial rashes is indeed in the range of 61-74%. This statistic highlights the dermatological manifestations of COVID-19, which have been increasingly recognized as part of the disease's symptomatology. Research has indicated that various skin conditions, including rashes, can occur in patients infected with the virus, with pruritic (itchy) rashes being particularly common.

The association of vesicular and urticarial rashes with COVID-19 is crucial for clinical awareness, as it can aid in the identification and diagnosis of the infection in patients presenting with atypical symptoms. This understanding is especially important in practice, as dermatological symptoms may sometimes precede other classic signs of COVID-19, prompting earlier interventions and improving patient outcomes.

In contrast, the other percentage ranges do not align with the current understanding of these dermatological symptoms in COVID-19 patients, which are more consistently documented within the 61-74% range based on observational studies and clinical reports.